调节 Dickkopf-1：一种监测或治疗癌症的策略？
Modulating Dickkopf-1: A Strategy to Monitor or Treat Cancer?
机构信息
CHU de Québec Research Center, 2705 Boulevard Laurier, RC-9800, Québec, QC G1V 4G2, Canada.
Department of Pediatrics, Université Laval, Québec, QC G1V 0A6, Canada.
出版信息
Cancers (Basel). 2016 Jun 28;8(7):62. doi: 10.3390/cancers8070062.
Abstract
Dickkopf-1 (DKK1) is a secreted Wnt/β-catenin pathway antagonist involved in embryogenesis. It was first described 25 years ago for its function in head induction and limb morphogenesis. Since then, this protein has been widely studied in the context of active Wnt/β-catenin signalling during cellular differentiation and development. Dysregulation of DKK1 has been associated with bone pathologies and has now emerged as a potential biomarker of cancer progression and prognosis for several types of malignancies. Reducing the amount of circulating DKK1 may reveal a simple and efficient strategy to limit or reverse cancer growth. This review will provide an overview of the role of Dickkopf-1 in cancer and explore its potential use as a biomarker and therapeutic target.
摘要
Dickkopf-1 (DKK1) 是一种分泌型 Wnt/β-catenin 通路拮抗剂，参与胚胎发生。25 年前，它因其在头部诱导和肢体形态发生中的功能而首次被描述。从那时起，在细胞分化和发育过程中，该蛋白在活跃的 Wnt/β-catenin 信号转导方面得到了广泛研究。DKK1 的失调与骨病理学有关，现在已成为多种恶性肿瘤进展和预后的潜在生物标志物。减少循环 DKK1 的量可能揭示出一种限制或逆转癌症生长的简单而有效的策略。本文综述了 Dickkopf-1 在癌症中的作用，并探讨了其作为生物标志物和治疗靶点的潜在用途。
相似文献
1
Modulating Dickkopf-1: A Strategy to Monitor or Treat Cancer?
Cancers (Basel). 2016 Jun 28;8(7):62. doi: 10.3390/cancers8070062.
2
Dickkopf-1 (Dkk1) protein expression in breast cancer with special reference to bone metastases.
Clin Exp Metastasis. 2018 Dec;35(8):763-775. doi: 10.1007/s10585-018-9937-3. Epub 2018 Sep 20.
3
Dickkopf-1 has an Inhibitory Effect on Mesenchymal Stem Cells to Fibroblast Differentiation.
Chin Med J (Engl). 2016 May 20;129(10):1200-7. doi: 10.4103/0366-6999.181974.
4
Wnt/β-Catenin Signaling Activation beyond Robust Nuclear β-Catenin Accumulation in Nondysplastic Barrett's Esophagus: Regulation via Dickkopf-1.
Neoplasia. 2015 Jul;17(7):598-611. doi: 10.1016/j.neo.2015.07.006.
5
Opposing Roles of Wnt Inhibitors IGFBP-4 and Dkk1 in Cardiac Ischemia by Differential Targeting of LRP5/6 and β-catenin.
Circulation. 2016 Dec 13;134(24):1991-2007. doi: 10.1161/CIRCULATIONAHA.116.024441. Epub 2016 Nov 1.
6
Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling.
Nature. 2002 Jun 6;417(6889):664-7. doi: 10.1038/nature756. Epub 2002 May 26.
7
Drug Discovery of DKK1 Inhibitors.
Front Pharmacol. 2022 Mar 9;13:847387. doi: 10.3389/fphar.2022.847387. eCollection 2022.
8
Dkk1 exacerbates doxorubicin-induced cardiotoxicity by inhibiting the Wnt/β-catenin signaling pathway.
J Cell Sci. 2019 May 16;132(10):jcs228478. doi: 10.1242/jcs.228478.
9
Significance of serum DKK1 as a diagnostic biomarker in hepatocellular carcinoma.
Future Oncol. 2012 Dec;8(12):1525-8. doi: 10.2217/fon.12.147.
10
Dickkopf-1 may regulate bone coupling by attenuating wnt/β-catenin signaling in chronic apical periodontitis.
Arch Oral Biol. 2018 Feb;86:94-100. doi: 10.1016/j.archoralbio.2017.11.012. Epub 2017 Dec 5.
引用本文的文献
1
Dickkopf-1 promotes tumor progression of gefitinib- resistant non-small cell lung cancer through cancer cell-fibroblast interactions.
Exp Hematol Oncol. 2025 Mar 1;14(1):24. doi: 10.1186/s40164-025-00616-9.
2
DKK1 and Its Receptors in Esophageal Adenocarcinoma: A Promising Molecular Target.
Diagnostics (Basel). 2025 Jan 2;15(1):85. doi: 10.3390/diagnostics15010085.
3
Prognostic value of cancer-associated fibroblasts-related genes in lung adenocarcinoma.
Transl Cancer Res. 2023 Aug 31;12(8):1895-1911. doi: 10.21037/tcr-23-199. Epub 2023 Jul 14.
4
Characterization of the Immune Infiltration Landscape and Identification of Prognostic Biomarkers for Esophageal Cancer.
Mol Biotechnol. 2023 Mar;65(3):361-383. doi: 10.1007/s12033-022-00526-9. Epub 2022 Jul 3.
5
Drug Discovery of DKK1 Inhibitors.
Front Pharmacol. 2022 Mar 9;13:847387. doi: 10.3389/fphar.2022.847387. eCollection 2022.
6
Dickkopf proteins in pathological inflammatory diseases.
J Leukoc Biol. 2022 Apr;111(4):893-901. doi: 10.1002/JLB.3RI0721-385R. Epub 2021 Dec 10.
7
The pro-angiogenesis effect of miR33a-5p/Ets-1/DKK1 signaling in ox-LDL induced HUVECs.
Int J Biol Sci. 2021 Oct 3;17(15):4122-4139. doi: 10.7150/ijbs.60302. eCollection 2021.
8
High Serum Levels of Wnt Signaling Antagonist Dickkopf-Related Protein 1 Are Associated with Impaired Overall Survival and Recurrence in Esophageal Cancer Patients.
Cancers (Basel). 2021 Oct 4;13(19):4980. doi: 10.3390/cancers13194980.
9
Expression and Role of Dickkopf-1 (Dkk1) in Tumors: From the Cells to the Patients.
Cancer Manag Res. 2021 Jan 25;13:659-675. doi: 10.2147/CMAR.S275172. eCollection 2021.
10
Serum Tumor Markers for Early Diagnosis of Primary Hepatocellular Carcinoma.
J Hepatocell Carcinoma. 2020 Dec 18;7:413-422. doi: 10.2147/JHC.S272762. eCollection 2020.
本文引用的文献
1
A monoclonal antibody against the Wnt signaling inhibitor dickkopf-1 inhibits osteosarcoma metastasis in a preclinical model.
Oncotarget. 2016 Apr 19;7(16):21114-23. doi: 10.18632/oncotarget.8522.
2
Prognostic Significance of Dickkopf-1 in Gastric Cancer Survival: A Meta-Analysis.
Genet Test Mol Biomarkers. 2016 Apr;20(4):170-5. doi: 10.1089/gtmb.2015.0154. Epub 2016 Mar 29.
3
Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.
Cancer Med. 2016 Jul;5(7):1388-96. doi: 10.1002/cam4.702. Epub 2016 Mar 14.
4
Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma.
PLoS One. 2016 Mar 17;11(3):e0151069. doi: 10.1371/journal.pone.0151069. eCollection 2016.
5
Serum Dickkopf-1 levels as a clinical and prognostic factor in patients with bladder cancer.
Genet Mol Res. 2015 Dec 28;14(4):18181-7. doi: 10.4238/2015.December.23.5.
6
Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer.
Oncotarget. 2015 Mar 20;6(8):5903-17. doi: 10.18632/oncotarget.3464.
7
High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients.
BMC Cancer. 2014 Sep 2;14:649. doi: 10.1186/1471-2407-14-649.
8
A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events.
Br J Haematol. 2014 Nov;167(3):366-75. doi: 10.1111/bjh.13056. Epub 2014 Aug 19.
9
Serum Dickkopf-1 expression level positively correlates with a poor prognosis in breast cancer.
Diagn Pathol. 2014 Aug 13;9:161. doi: 10.1186/s13000-014-0161-4.
10
The role of preoperative serum levels for Dickkopf-related protein 1 as a potential marker of tumor invasion in patients with stage II and III colon cancer.
Eur Rev Med Pharmacol Sci. 2014;18(12):1742-7.
Zotero 插件